I’m honored to be working with my friends and colleagues at the CTO Forum. Their efforts benchmarking technologies and strategies that address global challenges facing business, society and quality of life are making a significant impact.
Santa Clara, CA (PRWEB) September 11, 2013
The CTO Forum and PepsiCo today announced that Dr. Mehmood Khan, Executive Vice President and Chief Scientific Officer for PepsiCo, has been appointed to the CTO Forum Advisory Board. The CTO Forum brings together senior technology executives and business leaders in order to discuss and collaborate on key technology issues facing the industry and to accelerate innovation across organizations.
"We are very honored to welcome Mehmood Khan to our advisory board. He brings over twenty years of experience in the medical, pharmaceutical and food and beverage fields with a proven R&D track record. His knowledge, expertise and vision will be a huge asset for the CTO Forum,” said Basheer Janjua, founder and chairman of the CTO Forum and CEO of Integnology Corporation.
“I’m equally honored to be working with my friends and colleagues at the CTO Forum. Their efforts benchmarking technologies and strategies that address global challenges facing business, society and quality of life are making a significant impact,” said Dr. Mehmood Khan, Chief Scientific Officer, PepsiCo. “In so many ways, the CTO Forum serves the same purpose as our global R&D organization at PepsiCo, which is equally committed to global best practice exchanges across process, technology and product innovations critical to the future of PepsiCo.”
In his role at PepsiCo, starting in 2007, Mehmood Khan has led a strategic transformation to transform, grow and continually enhance the company’s global portfolio of high-quality food and beverage offerings. Under his leadership, the R&D team has led the development of important nutrition platforms such as fruits and vegetables, dairy, baked grains, and hummus and other fresh dips.
Over the past six years, in an effort to further develop categories and capture the growth opportunities of the future, the R&D function has expanded its research capabilities by recruiting highly regarded clinical and food scientists, global health leaders and medical experts, in addition to launching research projects with leading universities worldwide. In 2012 alone, PepsiCo opened three new R&D centers of excellence: in Hamburg, Germany, Shanghai; China; and Monterrey, Mexico.
Before joining PepsiCo, Dr. Khan was President, Takeda Global Research & Development Center, overseeing its worldwide research and development efforts with sales of over $10 billion worldwide. Previous to that position, Dr. Khan was a consultant endocrinologist and faculty member at the Mayo Clinic and Mayo Medical School in Rochester, Minn., serving also as the Director of the Diabetes, Endocrine and Nutritional Trials Unit in the division of endocrinology. Prior to the Mayo Clinic, he spent nine years leading programs in diabetes, endocrinology, metabolism, and nutrition including as Chief of Endocrinology for the Hennepin County Medical Center in Minneapolis, University of MN. He has served as faculty both in the department of Food Sciences, College of Agriculture and the Medical School at the University of MN.
Dr. Khan serves on a number of national and state committees including as a Governor of the New York Academy of Sciences, a member of the State of Illinois Innovation Council and a member of the Board of the American Diabetes Association Research Foundation as well as several humanitarian organizations. He earned his medical degree from the University of Liverpool Medical School, England, and completed a fellowship in clinical endocrinology and nutrition at the University of Minnesota-Minneapolis Department of Medicine and Food Science and Nutrition.